New Orders Received in Medical Imaging Thu, 27th Feb 2014 07:00 RNS Number : 0459B Kromek Group PLC 27 February 2014
Embargoed until: 0700hrs, 27 February 2014
Kromek Group plc
("Kromek" or "the Company")
New Orders Received in Medical Imaging
Kromek, a supplier of patented radiation detection technologies to the medical, security and nuclear markets, announces that it has secured $845,000 of new orders to supply radiation detectors and integrated electronic components to a globally leading Original Equipment Manufacturer ('OEM') operating in the Dual Energy X-ray Bone Mineral Densitometry ('DEXA BMD') market. The total booking this fiscal year from this customer now exceeds $1.25 million.
DEXA BMD is the most accurate imaging technique to diagnose the strength and health of bones, allowing clinicians to accurately detect, monitor and treat Osteoporosis in patients. DEXA BMD is another medical diagnostic imaging modality where improved x-ray detection and imaging detail helps early diagnostics and intervention, which enables healthcare providers to operate more efficiently and manage costs against a backdrop of global healthcare budget pressures.
The new orders to supply detection components based on Kromek's Cadmium Zinc Telluride ('CZT') technology, are in addition to an existing contract the Company has in place with the OEM partner, in a global BMD market expected to surpass $895 million by 2017.
Commenting on the announcement, Arnab Basu, CEO of Kromek, said: "This latest order from this existing OEM partner builds on an important international relationship as we continue to see growth through expanding our geographic reach, particularly in Asia.
"Our work in BMD helps clinicians to detect and treat Osteoporosis earlier and is further validation of our technology and its capabilities in improving the efficacy of medical scanning technologies. This latest success adds to the encouraging progress we have seen in the wider medical imaging space, as evidenced by our announcement in November 2013 of a $990,000 contract to supply components to the nuclear medicine market, alongside the up to $5.3 million development contract we received in the x-ray CT scanning space. We have multiple blue-chip customers in the medical imaging sector and are seeing excellent traction in the adoption of our components. We look forward to announcing further progress in due course."
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.